WA
BRLI

Wasatch Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Wasatch Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-73,012
Closed -$3.01M – 395
2015
Q2 		$3.01M Sell
73,012
-60,000
-45% -$2.15M 0.03% 284
2015
Q1 		$4.69M Hold
133,012
– – 0.05% 239
2014
Q4 		$4.27M Buy
133,012
+17,500
+15% +$506K 0.04% 260
2014
Q3 		$3.24M Buy
115,512
+17,001
+17% +$518K 0.03% 280
2014
Q2 		$2.98M Sell
98,511
-186,315
-65% -$5.14M 0.03% 300
2014
Q1 		$7.88M Sell
284,826
-52,020
-15% -$1.36M 0.08% 215
2013
Q4 		$8.6M Sell
336,846
-148,822
-31% -$4.59M 0.08% 201
2013
Q3 		$14.5M Buy
485,668
+93,685
+24% +$2.61M 0.15% 172
2013
Q2 		$11.3M Buy
+391,983
New +$10.8M 0.12% 194

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Wasatch Advisors's BRLI Position: Q3 2015 in Review

Wasatch Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 73,012 shares — an estimated $3.01M sold.

Wasatch Advisors first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $14.5M in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Wasatch Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Wasatch Advisors sold 73,012 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $3.01M.
  • Wasatch Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Wasatch Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $14.5M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Wasatch Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.